VHL and renal cell adenocarcinoma: Two patients (2/22) ( 9%) showed the same JAK3 mutation variant (V722I); it was associated with a VHL 1 mutation and was revealed both in the sarcomatoid and rhadboid component of the same patient, while in the other patient it was present as a single mutation in the primary RCC and the metastatic lesion.